This page is the continuation of references in support of Section 5B
REFERENCES
Amin MB, Tamboli P, Merchant SH, Ordóñez NG, Ro J, Ayala AG, Ro JY. (2002) Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. Mar;26(3):358-64. (Retrieved 19th April 2015): http://www.ncbi.nlm.nih.gov/pubmed/20610543
Chapman AD, Kerr KM. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer 2000;83:632–6. (Retrieved 10th Feb 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363514/pdf/83-6691317a.pdf
Chirieac LR, Flieder DB. (2010) High-Resolution Computed Tomographic Screening for Lung Cancer. Unexpected Findings and New Controversies Regarding Adenocarcinogenesis. Arch Pathol Lab Med 134,41-48. (Retrieved 10th Feb 2015): http://www.archivesofpathology.org/doi/pdf/10.1043/1543-2165-134.1.41
Cho KR, Vogelstein B. Genetic alterations in the adenoma–carcinoma sequence. Cancer 1992;70:1727–31. (Retrieved 10th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/1516027?dopt=Abstract
Cooke DT, Nguyen DV, Yang Y et al. (2010). Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy. Ann Thorac Surg. 2010;90(3):943. (Retrieved 12th Feb 2015): http://www.annalsthoracicsurgery.org/article/S0003-4975(10)01188-4/pdf
Pao W, Girard N. (2011). New driver mutations in non-small-cell lung cancer. Lancet Oncol 12 (2): 175-80, 2011. (Retrieved Feb 12th 2015): http://www.ncbi.nlm.nih.gov/pubmed/21277552?dopt=Abstract
Silver SA, Askin FB. (1997) True papillary carcinoma of the lung: a distinct clinicopathologic entity. Am J Surg Pathol.Jan;21(1):43-51 (Retrieved 20th April 2015): http://www.ncbi.nlm.nih.gov/pubmed/8990140
Silvestri GA, Gonzalez AV, Jantz MA, et al. (2013). Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl), e211S. (Retrieved 29th Jan 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1685830
Travis WD, Brambilla E, Noguchi M, et al. (2011). International Association for the Study of Lung Cancer/American Thoracic Society/ European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 6(2):244–85. (Retrieved 22nd Jan 2015): http://www.ncbi.nlm.nih.gov/pubmed/21252716
Travis WD, Brambilla E, Noguchi M et al. (2011). International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: Classification of Lung Adenocarcinoma. Proceedings of the American Thoracic Society 8(5), 381-385. (Retrieved Feb 12th 2015): http://www.atsjournals.org/doi/full/10.1513/pats.201107-042ST#.VNslZil63ww
Travis, WD, Brambilla, E, Muller-Hermlink, HK, Harris, CC (eds). World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press. Lyon 2004.
WHO Classification of Tumors of the Lung. 3rd Edition. (Retrieved 10th Feb 2015): http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf
